https://www.profitableratecpm.com/f4ffsdxe?key=39b1ebce72f3758345b2155c98e6709c
(MedPage Today) — CHICAGO — Almost two-thirds of teens with plaque psoriasis saw complete skin clearance after 6 months of treatment with icotrokinra, an investigational oral peptide drug that blocks interleukin-23 (IL-23), according to phase…
